Similarly, Rashid et al. [89] stated that the administration of TAU resulted in the downregulation of Bax and caspase-3 expression and upregulation of Bcl-2 in the hepatic tissues of rats with alloxan-induced diabetes. The gene discussed is BCL2; the disease is diabetes mellitus.